Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Karyopharm’s multiple myeloma drug Xpovio

pharmaceutical-technologyJuly 05, 2019

Tag: FDA , Karyopharm , multiple myeloma drug

PharmaSources Customer Service